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Background. Reliable predictive factors for therapy outcome may enable treating physicians to counsel their patients more
efficiently concerning probability of improvement or time point of discontinuation of a certain therapy. Methods. This is a
retrospective analysis of 87 patients with exudative age-related macular degeneration who received three monthly intravitreal
ranibizumab injections. Visual acuity before initiation of intravitreal therapy and 4–6 weeks after last intravitreal injection was
compared and related to the preoperative visualisation of continuity of the outer retinal layers as assessed by OCT: external
limiting membrane (ELM), inner photoreceptor segments (IPS), junction between inner and outer segments (IS/OS), and
outer photoreceptor segments (OPS). Results. Visual acuity increased in 40 of 87 (46.0%) patients, it remained stable in 25
(28.7%), and 22 (25.3%) patients had decreased visual acuity four to six weeks after triple intravitreal ranibizumab injections.
No statistically significant predictive value could be demonstrated for grade of continuity of outer retinal layers concerning visual
acuity development. Conclusions. In our series of AMD patients, grade of continuity of outer retinal layers was not a significant
predictive value for visual acuity development after triple ranibizumab injections.
1. Introduction
Therapy of exudative age-related macular degeneration
(AMD) with anti-vascular endothelial growth factor (VEGF)
substances has evolved to an effective and widespread
treatment in the last years, allowing preservation or even
improvement of visual acuity in the short and long term [1–
3]. Nevertheless, some patients fail to show improvement
in visual acuity despite proven activity of the neovascular
complex before beginning of therapy and anatomical success
thereafter. Predictions concerning probability and amount of
visual improvement still remain difficult, and counseling of
patients is therefore challenging.
Improvements in optical coherence tomography (OCT)
devices allow higher resolution of the imaged retina, and
the assessment of the integrity of retinal layers becomes
more and more feasible [4, 5]. Conclusions concerning the
functionality of the single layers or their interaction may
become possible and thus serve as a surrogative marker
for the efficacy of certain therapies. Some publications
already describe the importance of intact outer retinal
layers, especially of the junction between inner and outer
photoreceptor layers, for good visual acuity [6–10].
In the study presented, we investigated the predictive
value of the outer retinal layers as visualized by OCT
in relation to postoperative visual acuity in patients with
exudative AMD receiving three intravitreal ranibizumab
injections.
2. Methods
This is a retrospective chart review of 100 consecutive
patients with treatment naı¨ve subfoveal exudative AMD,
who received three monthly intravitreal injections with
ranibizumab (Lucentis, Novartis International AG, Basel,
Switzerland). All patients were diagnosed with active sub-
foveal choroidal neovascular membrane (CNV) before treat-
ment initiation. Patients received complete ophthalmologic
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Figure 1: Spectral domain OCT scan of the retinal layers in
a normal macula: ELM: external limiting membrane, IPS: inner
photoreceptor segments, IS/OS: junction between inner and outer
photoreceptor segments, and OPS: outer photoreceptor segments.
exam including decimal best corrected visual acuity (BCVA),
dilated fundus ophthalmoscopy, fundus photography, flu-
orescein angiography to confirm the diagnosis (Heidel-
berg Retina Angiograph 2, Heidelberg Engineering, Heidel-
berg, Germany), and OCT imaging (Spectralis, Heidelberg
Engineering, Heidelberg, Germany). Decimal BCVA was
converted to logMAR for statistical reasons. Four to six
weeks after third intravitreal injection, patients routinely
presented for follow-up examination including BCVA and
OCT imaging.
Preoperative OCT images were retrospectively evaluated
concerning grade of continuity of the outer retinal layers,
namely, the external limiting membrane (ELM), the inner
photoreceptor segments (IPS), the junction between inner
and outer photoreceptor segments (IS/OS), and the outer
photoreceptor segments (OPS) (Figure 1). Gray-scale single-
line (6mm) horizontal OCT images centered on the fovea if
visible, or approximating it, were used for this purpose, each
image being averaged from 9 scans. Continuity of the outer
retinal layers was evaluated over the whole width of the neo-
vascular lesion. For ELM and IS/OS, continuity was classified
in three categories: good visualization with continuity over
the whole neovascular complex (+), moderate visualization
with focal discontinuity (±), and low or no visualization
over more than 50% of the neovascular complex (−). For
IPS, and OPS, continuity was classified in good/smooth
appearance (+) or low/ragged appearance (−), because no
patient showed complete invisibility of IPS or OPS.
Patients were divided into three groups depending on
postoperative development of BCVA: group 1 had improve-
ment of vision ≥1 logMAR line, group 2 stabilisation, and
group 3 loss of visual acuity ≥1 logMAR line. A second
analysis was carried out with patients in group 1 improving
≥3 lines, patients in group 2 stabilizing at ±2 lines, and
patients in group 3 loosing ≥3 lines. Preoperative grade
of continuity of outer retinal layers was then correlated to
postoperative development of visual acuity.
Statistical analysis was performed using Fisher’s exact test
two sided with an α-level of 5% for the comparison of rates
between groups.
Because of the retrospective and noninterventional study
design, and because the data presented here cannot be related
to personal patient data, the institutional ethics committee
review board rated this study not to require an official
approval.
3. Results
3.1. Overall Results. Charts and images of 100 consecutive
patients were reviewed for this investigation. Of these, five
patients missed the followup, and quality of OCT images
of eight patients was too low for evaluation. Data of the
remaining 87 patients was included in the final analysis.
59 female and 28 male patients, 42 right and 45 left eyes,
were treated. All patients had naı¨ve subfoveal exudative AMD
in the studied eye that was categorized to the different
CNV-subtypes according to fluorescein angiography: 10 of
87 patients (11.5%) had predominantly classic CNV, 18
(20.7%) hadminimal classic CNV, and 59 (67.8%) had occult
CNV. As graded by OCT imaging, 31 patients (35.6%) had
intraretinal fluid accumulation with cystoid spaces only, 34
patients (39.1%) had subretinal fluid accumulation only, and
22 patients (25.3%) had combined intra- and subretinal fluid
accumulation.
Out of 87 patients, 40 (46.0%) experienced improvement
in visual acuity ≥ 1 line, 25 (28.7%) remained stable, and
22 (25.3%) had decreased visual acuity ≥1 line four to six
weeks after triple intravitreal ranibizumab injections. When
considering improvement or loss of visual acuity of three
or more lines, 18 (20.7%) patients improved, 64 (73.6%)
remained stable, and 5 (5.7%) suffered from deterioration of
visual acuity.
Overall (all patients taken together without discrimina-
tion concerning visual acuity), 27 (31%) out of 87 patients
showed (+) ELM continuity, 30 (34.5%) patients (±) and 30
(34.5%) patients (−) ELM continuity. The IS/OS border was
graded as showing (+) continuity in 15 (17.2%) patients, (±)
in 33 (38.0%) patients, and (−) in 39 (44.8%) patients. Inner
photoreceptors were (+) in 31 (35.6%) and (−) in 56 (64.4%)
patients. Outer photoreceptors, respectively, were (+) in 9
(10.3%) and (−) in 78 (89.7%) patients.
Out of 27 patients with (+) ELM and considering visual
gain or loss of one or more lines, 15 (55.6%) had improved
visual acuity, 8 (29.6%) remained stable, and 4 (14.8%) lost
vision (Figure 2). No patient had concurrent (−) IS/OS.
Out of 30 patients with (−) ELM, 27 (90%) had also (−)
IS/OS. Out of these 27 patients with (−) ELM and (−) IS/OS,
10 (37.1%) gained visual acuity, 9 (33.3%) remained stable,
and 8 (29.6%) lost vision (Figure 3).
3.2. Predictive Value
3.2.1. Good-Poor-No Continuity of Outer Retinal Layers.
Concerning the predictive value of good versus poor versus
no continuity of the outer retinal layers ELM, IS/OS, IPS,
and OPS, statistical analysis did not reveal any significant
value for any group when patients were stratified after visual
acuity development (improved ≥ 1 line, stable, deteriorated
≥ 1 line): ELM P = 0.5879, IS/OS P = 0.7737, IPS P =
0.9579, and OPS P = 0.4951. Stratification of patients with
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Figure 2: Group of patients with good continuity of ELM and IS/OS over the CNV lesion: exemplary baseline OCT images and final
distribution of patients with improved, stable, or decreased vision after triple intravitreal ranibizumab therapy, (Brackets define the area of
the CNV lesion. Arrowheads = ELM. Arrows = IS/OS border.).
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Figure 3: Group of patients with poor continuity of ELM and IS/OS over the CNV lesion: exemplary baseline OCT images and final
distribution of patients with improved, stable, or decreased vision after triple intravitreal ranibizumab therapy (Brackets define the area of
the CNV lesion. Arrowheads = ELM. Arrows = IS/OS border.).
improvement/loss of ≥3 lines did not result in significant
predictive values, either, concerning ELM P = 0.2625, IS/OS
P = 0.6987, and OPS P = 0.8147. Only the visibility of
IPS was correlated with visual acuity development, when
considering improvement/loss of ≥3 lines: P = 0.0169
(Table 1).
3.2.2. Good Poor/No Continuity of Outer Retinal Layers. In a
second assessment, the groups with (±) and (−) continuity
of ELM and IS/OS, respectively, were combined and com-
pared to patients with (+) continuity of ELM and IS/OS for
the predictive value in relation to visual acuity development.
Again, no significant value was obtained: ELM P =
0.3318, IS/OS P = 0.5457 for stratification ≥ 1 line and
ELM P = 0.1987, IS/OS P = 0.5130 for stratification ≥
3 lines. Likewise, no significant predictive value was found
when visual acuity groups of stable and deteriorated visual
acuity were combined and compared to the patients with
improved visual acuity: ELM P = 0.2532, IS/OS P = 0.5789
for stratification ≥ 1 line and ELM P = 0.5679, IS/OS P =
0.7267 for stratification ≥ 3 lines.
Table 1
VA
improved
±1 line
(±3 lines)
VA stable
±1 line
(±3 lines)
VA deteri-
orated
±1 line
(±3 lines)
+
ELM ± P = 0.5879 (P = 0.2625)
−
+
OS/OS ± P = 0.7737 (P = 0.6987)
−
IPS
+ P = 0.9579 (P = 0.0169)
−
OPS + P = 0.4951 (P = 0.8147)
−
3.2.3. Good/Poor-No Continuity of Outer Retinal Layers. In a
third assessment, the groups with (+) and (±) continuity of
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Figure 4: Distribution of patients with intraretinal cystoid edema
versus subretinal fluid accumulation in OCT imaging on baseline,
in relation to the final visual acuity.
ELM and IS/OS, respectively, were combined and compared
to patients with (−) continuity of ELM and IS/OS in the same
manner.
Again, no significant value was obtained: ELM P =
0.9178, IS/OS P = 0.7564 for stratification ≥ 1 line and ELM
P = 0.2430, IS/OS P = 0.6383 for stratification ≥3 lines.
Nor was any significance seen when visual acuity groups
were combined: ELM P = 0.8221, IS/OS P = 0.5169 for
stratification ≥ 1 line and ELM P = 0.1641, IS/OS P =
0.4255 for stratification ≥ 3 lines.
3.3. Influence of Fluid Accumulations
3.3.1. On Visual Acuity Development. Patients improving
in vision 4–6 weeks after triple intravitreal ranibizumab
injections had prorata substantially less intraretinal fluid
accumulation and more subretinal fluid accumulation on
baseline OCT: cystoid macular edema was seen in 20% of
patients with improved vision compared to 52% and 45.5%
of patients with stable or decreased vision, respectively. Sub-
retinal fluid was present in 47.5% of patients with improved
visual acuity, compared to 32% and 31.8% of patients with
stable or decreased vision, respectively (Figure 4).
Combined intra- and subretinal fluid accumulations
were present in 32.5% of patients with improved vision, and
in 16% and 22.7% of patients with stable or decreased vision,
respectively.
3.3.2. On Continuity of Outer Retinal Layers. Presence of
intraretinal fluid accumulations (cystoid edema) on baseline
OCT was associated with less patients displaying good
continuity of ELM and IS/OS on OCT images regardless of
visual acuity development. In patients with improved vision
and intraretinal cystoid spaces, ELM and IS/OS each was
rated as displaying good continuity in only 7.5% of patients.
In patients with subretinal fluid only, good continuity of
ELM and IS/OS was seen in 30% and 12,5% of patients,
respectively. This distribution was similar in the groups of
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Figure 5: Percentage of patients displaying good continuity of
external limiting membrane on baseline OCT and with either con-
current intraretinal cystoid edema or subretinal fluid accumulation,
in relation to the final visual acuity.
patients with stable vision as well as patients with decreased
vision (data not shown).
Concerning only continuity of ELM and comparing
groups of patients with improved versus stable versus
decreased vision, good continuity of ELMdespite intraretinal
cystoid spaces was seen in 7.5%, 8%, and 0% of patients,
respectively, while good continuity of ELM in the presence
of subretinal fluid was seen in 30%, 20%, and 18.2%,
respectively (Figure 5).
4. Discussion
Identification of predictive factors is of increasing impor-
tance as more efficacious therapies in a variety of oph-
thalmologic subfields become available. During the last
years, predictive factors were primarily assessed as baseline
morphologic features in the treated tissues or baseline patient
characteristics such as age, BCVA, or previous interventions
[11–13]. In AMD, for example, low initial BCVA, increased
central retinal thickness in OCT and treatment naı¨ve patients
were found to be associated with an improvement in visual
acuity after intravitreal bevacizumab therapy [12].
Due to advances in the resolution of OCT devices, in
vivo imaging of retinal layers and, furthermore, assessment
of integrity of those layers become more and more feasible
in everyday routine [4, 5], and even subtle changes may be
observed in a longitudinal fashion. In the outer retinal layers,
the third hyperreflective line corresponding to the IS/OS
junction represents the border between the highly organized
outer photoreceptor segments and their inner myoid parts.
The fine line overlying the IS/OS junction depicts the ELM
and, thus, identifies the border between inner photoreceptor
segments and outer nuclear layer comprising the photorecep-
tor cell bodies and—in the fovea—the apexes of the Mu¨ller
cells [14].
In patients with cystoid macular edema associated with
retinitis pigmentosa, Oishi and coworkers could show that
the integrity of the IS/OS junction was strongly correlated
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with visual acuity, while total retinal thickness or thickness
of the photoreceptor layer was not [6]. Also, visual acuity
after therapy for different diseases was found to correlate to
the postoperative integrity of the IS/OS junction [7–10]. This
finding is not surprising as the integrity of IS/OS junction
and visualization of this line in OCT imaging indicates
integrity of the photoreceptor system. Furthermore, integrity
of ELM would suggest integrity of both inner photoreceptor
segments and outer nuclear layer, the thickness of which was
also correlated with good visual acuity [8].
However, only few publications are available up to
now assessing the predictive value of the continuity of
outer retinal layers. Suh and coworkers showed that eyes
with disruption of IS/OS junction on preoperative OCT
had significantly lower postoperative BCVA after removal
of epiretinal membranes [15]. However, although visual
acuity may be biased as some patients also had cataract
operation and/or triamcinolone injection at the end of the
operative procedure, this study hints to the importance of
integrity of IS/OS junction for good visual performance. In
addition, Wakabayashi and co-workers correlated the intact
ELM and IS/OS junction one month after successful retinal
detachment repair with further visual acuity improvement.
Furthermore, they stress the importance of an intact ELM
both for final visual acuity development and also for possible
restoration of disrupted IS/OS junction in the followup. They
postulate that restoration of photoreceptors is possible as
long as the degenerative changes have not yet reached the
cell bodies [16]. In a recent publication, Wolf-Schnurrbusch
and colleagues showed that visual acuity improvement in
patients with central retinal vein occlusion 4 weeks after
single intravitreal anti-VEGF injection is associated with an
intact ELM [17].
In our study population of exudative AMD patients, the
grade of continuity, and thereby integrity, of none of the
outer retinal layers including ELM and IS/OS junction was
associated with visual acuity development when considering
change of visual acuity of more than one line. The single
significant value concerning the IPS when considering
change in visual acuity of more than three lines might have
been biased by the very small number of patients in these
groups and will have to be reevaluated in a larger series. On
the other hand, although initial OCT imaging showed ELM
and IS/OS discontinuity in 34.5% and 44.8% of patients,
respectively, only 25.3% had deterioration in postoperative
visual acuity. Likewise, while a significant part of patients
(89.7%) showed poor/ragged appearance of OPS on initial
OCT images, visual acuity nevertheless improved in 46%
after ranibizumab injections. This may support the hypoth-
esis that disrupted or ragged outer photoreceptor layers may
regenerate with time and thereby allow patients to improve
in visual acuity [16]. Also, in a study population comprising
exudative AMD, disorganisation of retinal layers is much
more extensive than in the above-mentioned publications of
epiretinal membrane peeling or retinal detachment surgery
[15, 16]. In our series of exudative AMDpatients, intraretinal
cystoid edema was associated with a poorer visual prognosis
as well as with lower grades of continuity of outer retinal
layers than subretinal fluid accumulation. On the other
hand, an increased amount of intraretinal fluid accumulation
before beginning of therapy may reduce the visibility and
assessibility of the retinal layers by increased absorption
and backscattering of signals, thereby biasing the predic-
tive potency of the images: while good visualization and
continuity of ELM and IS/OS junction is associated with a
higher probability of improved vision in our study, although
not statistically significant, poor visualization and continuity
does not allow any prediction concerning visual acuity
development. Therefore, presence of intraretinal cystoid
spaces should caution in predictions of visual acuity.
The limitations of this study are its retrospective nature
and highly mixed patient population of everyday routine
out-patient service, as well as the short followup of only
4 to 6 weeks after upload injections and the averaging of
only 9 scans per OCT image. Nevertheless, as anti-VEGF-
therapy shows a steep improvement in vision during upload-
injections and a plateau forming afterwards, we felt that even
this short followup would give good information about the
predictive value of OCT images.
Therefore, and although most publications dealing with
the predictive value of outer retinal layers stress the impor-
tance of integrity of outer retinal layers for good visual
acuity, we would like to caution for the reverse, as not all
patients with poor visualization or even discontinuity of
outer retinal layers deteriorate in the followup. More detailed
and specific factors are therefore needed for exact prediction
of postoperative visual development.
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